Showing results (181-190 of 254) with videos related to

Sort By:
Pageof 26
International Journal of Antimicrobial Agents|July 13, 2026
Outcomes for persons with triple-class resistant HIV and a history of virologic failureSuzanne M Ingle, Fabrice Bonnet, Linda Wittkop, et al.
Scientific Reports|October 26, 2018
Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalenceClaudia Alteri, Lavinia Fabeni, Rossana Scutari, et al.
The Journal of General Virology|October 12, 2012
Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolutionValeria Cento, Carmen Mirabelli, Salvatore Dimonte, et al.
Diagnostic Microbiology and Infectious Disease|December 5, 2021
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countriesJoseph Fokam, Ezechiel Ngoufack Jagni Semengue, Daniele Armenia, et al.
Cells|July 5, 2019
NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected PatientsMaria Concetta Bellocchi, Marianna Aragri, Luca Carioti, et al.
Cells|August 26, 2022
Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 PatientsMaria Antonella Zingaropoli, Marco Iannetta, Lorenzo Piermatteo, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2015
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 UsageClaudia Alteri, Matteo Surdo, Maria Concetta Bellocchi, et al.
Viruses|July 29, 2023
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line RegimensJoseph Fokam, Collins Ambe Chenwi, Valère Tala, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 13, 2010
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemiaValentina Svicher, Claudia Alteri, Caterina Gori, et al.
Biomedicines|October 23, 2021
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV ReactivationLorenzo Piermatteo, Mohammad Alkhatib, Stefano D'Anna, et al.
Pageof 26